Bangladesh to purchase 7cr doses of J&J vaccine
Published: 01:46 PM, 22 June 2021
Johnson & Johnson`s coronavirus vaccine, called Janssen,
To ensure vaccination for all, Bangladesh is going to purchase seven crore doses of the Johnson & Johnson's coronavirus vaccine, called Janssen, using the Covid-19 Vaccines Global Access (Covax) facility.
The Covax facility is a global initiative coordinated by the World Health Organization (WHO), the Vaccine Alliance Gavi, and the Coalition for Epidemic Preparedness Innovations.
The concerned officials said that the government has, in principle, decided to procure the single-dose Johnson & Johnson vaccine, which will be available from next June.
The vaccine will be purchased using the Asian Development Bank (ADB) fund.
On June 15, the Directorate General of Drug Administration (DGDA) issued an emergency use authorisation (EUA) for Johnson & Johnson's Covid-19 vaccine in the country.
It is the first single-dose Covid-19 vaccine approved for emergency use in the country. Earlier, the DGDA approved five double-dose Covid-19 vaccines for emergency use in Bangladesh.
WHO, the European Medicines Agency (EMA) and the Food and Drug Administration of the United States of America and Health Canada have already approved this vaccine for emergency use.